8 hrs ago | Medical News
Tripep completes clinical trial of ChronVac-C for treatment of Hepatitis C virus
All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep's therapeutic vaccine ChronVac-CA have now been collected.
New data emerges on liver transplant survival rates
Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis versus alcoholic liver disease and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups.
Medical Students Regularly Stuck By Needles, Often Fail To Report Injuries
Medical students are commonly stuck by needles - putting them at risk of contracting potentially dangerous blood-borne diseases - and many of them fail to report the injuries to hospital authorities, according to a Johns Hopkins study published in the December issue of the journal Academic Medicine.
Human Genome Sciences says it filed application for hepatitis C drug candidate Zalbin
Human Genome Sciences Inc. said Wednesday it has filed for marketing approval of its hepatitis C drug Zalbin.
Gilead in Asian deal for hepatitis B drug
Gilead Sciences Inc. and GlaxoSmithKline on Tuesday announced an agreement to commercialize Viread for the treatment of chronic hepatitis B infection in adults in five countries in Asia.
Alarming trend: Antiviral therapy to treat hepatitis C is declining in the US
Treatment rates appear to be declining, in part because only half of the patients know they are infected.
NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients...
New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the ...
Toward Explaining Why Hepatitis B Hits Men Harder Than Women
Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus sexually discriminates -- hitting men harder than women.
Daily News: Bill Would Fund Hepatitis Fight
A bipartisan bill allocating support for hepatitis infection prevention and treatment has been introduced into the U.S. House of Representatives.
AIIMS advocates special test to make blood transfusion safer
New Delhi, Nov 21 : About 20,000 patients in India could be at risk of getting infected blood -- unknown to them and even the donors.
Revised European HIV Treatment Guidelines Emphasize Management of...
SUMMARY: The European AIDS Clinical Society released updated HIV treatment guidelines last week at the group's annual conference in Cologne.
InterMune Announces Modification To On-Going Phase 2b Study Of...
Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 18 Nov 2009 - 3:00 PST InterMune, Inc.
New treatment for hemophilia launched in India
A new genetically engineered treatment for hemophilia, a dreaded disease where blood doesn't clot, was launched here Wednesday by a private pharmaceutical company.
Largest-ever Database For Liver Proteins May Lead To Treatments For Hepatitis
Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ.
Saskatchewan HIV-AIDS infection rates on the rise
Delegates of Saskatchewana TMs third annual Aboriginal HIV-AIDS and Hepatitis C conference marched through downtown Regina for missing First Nations women on Sunday.
There are ancient songs First Nations women used to sing in the forest to heal their injured men, songs of anguish and of strength, set to the heartbeat rhythm of a healing drum.
Hepatitis, HIV fear over unclean hospital
MORE than 270 people will need to be tested for blood borne diseases after a failure in sterilisation procedures at a southern Queensland hospital.
Characteristics of delta hepatitis in central Europe
The latest issue of the Journal of Viral Hepatitis investigates Virological and clinical characteristics of delta hepatitis in Central Europe.
Hepatitis C virus infection is a risk factor for gallstones
Hepatitis C virus infection is a risk factor for gallstone disease, finds the most recent issue of the Journal of Viral Hepatitis.
Bankruptcy trustee: Leave the hepatitis claims to us
The massive assortment of lawsuits over last year's hepatitis outbreak could be taking another detour.
Also on Topix